menu
    • menu

    Company profile for Allgenesis Biotherapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Allgenesis is a privately owned, clinical-stage, biopharmaceutical company situated in Taipei City, Taiwan. We strive to find solutions for major diseases of the eye affecting the vision of millions of people worldwide. Our mission is to establish a world-renowned biopharmaceutical business in Taiwan to invent and develop novel medicines for the global market.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Allgenesis BiotherapeuticsTaiwan Flag
    Country
    Country
    Taiwan
    Address
    Address
    9F.-3, No.760, Sec. 4, Bade Rd., Songshan Dist., Taipei City 105
    Telephone
    Telephone
    +886-2-8787-1232
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.allgenesis.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Allgenesis Announces Encouraging Safety and Efficacy Data from the AG-73305
    Allgenesis Announces Encouraging Safety and Efficacy Data from the AG-73305

    08 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/allgenesis-announces-encouraging-preliminary-safety-and-efficacy-data-from-the-ag-73305-phase-2a-trial-for-the-treatment-of-diabetic-macular-edema-at-american-academy-of-ophthalmology-301981763.html

    PR NEWSWIRE
    08 Nov 2023
    Share Share
    Allgenesis unveils encouraging data from trial of dry eye disease therapy
    Allgenesis unveils encouraging data from trial of dry eye disease therapy

    20 Jun 2023

    // CLINICAL TRIALS ARENA

    https://www.clinicaltrialsarena.com/news/allgenesis-data-dry-eye-disease/

    CLINICAL TRIALS ARENA
    20 Jun 2023
    Share Share
    Allgenesis Announces Encouraging Ph1b Data AG-80308 Providing Improvements
    Allgenesis Announces Encouraging Ph1b Data AG-80308 Providing Improvements

    19 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/allgenesis-announces-encouraging-phase-1b-data-showing-ag-80308-providing-improvements-in-multiple-signs-and-symptoms-in-dry-eye-patients-301853236.html

    PR NEWSWIRE
    19 Jun 2023
    Share Share
    Allgenesis touts preliminary data from Phase IIa diabetic macular oedema trial
    Allgenesis touts preliminary data from Phase IIa diabetic macular oedema trial

    24 May 2023

    // CLINICAL TRIALS ARENA

    https://www.clinicaltrialsarena.com/news/allgenesis-diabetic-macular-oedema/

    CLINICAL TRIALS ARENA
    24 May 2023
    Share Share
    Allgenesis Announces afety and Efficacy Data from te AG-73305
    Allgenesis Announces afety and Efficacy Data from te AG-73305

    23 May 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/allgenesis-announces-encouraging-preliminary-safety-and-efficacy-data-from-the-ag-73305-phase-2a-trial-for-the-treatment-of-diabetic-macular-edema-301832903.html

    PR NEWSWIRE
    23 May 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search